EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -126.86% | 527.18% | 49.22% | -530.18% | 25.51% |
| Total Depreciation and Amortization | 0.00% | -1.01% | -18.44% | 0.41% | 9.95% |
| Total Amortization of Deferred Charges | -18.58% | -1.74% | 6.48% | 33.33% | -4.71% |
| Total Other Non-Cash Items | 114.43% | -4,935.36% | -175.95% | 201.63% | -554.63% |
| Change in Net Operating Assets | -30.40% | -51.54% | 5.34% | 105.07% | 333.80% |
| Cash from Operations | 90.29% | -532.10% | 102.75% | -711.41% | 124.11% |
| Capital Expenditure | -- | 100.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -7,245.61% | -338.71% | 430.67% | -- |
| Total Debt Issued | -100.00% | -- | -- | -87.17% | -79.69% |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | 50.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 22,966.67% | -101.54% | 3,157.10% | -84.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.55% | -1,015.97% | -108.78% | 952.00% | 5,676.92% |
